Skip to main content
. 2021 Aug 26;14(11):101211. doi: 10.1016/j.tranon.2021.101211

Table 6.

MVA model with KLK3 (Decipher®).

BCR Metastasis PCSM
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
KLK3 0.85 (0.69–1.06) 0.154 0.72 (0.57–0.91) 0.007 0.6 (0.46–0.78) < 0.001
PSA 1 (0.99–1.02) 0.983 1.01 (1–1.03) 0.205 0.6 (0.46–0.78) 0.327
pT stage
 pT2 Ref (-) Ref (-) Ref (-)
 pT3a 1.79 (1.2–2.66) 0.004 1.53 (0.95–2.46) 0.079 0.6 (0.46–0.78) 0.619
 pT3b 3.48 (2.19–5.6) < 0.001 3.92 (2.42–6.41) < 0.001 1.01 (0.99–1.02) 0.014
GGG
GGG = < 2 Ref (-) Ref (-) Ref (-)
 GGG3 1.13 (0.71–1.82) 0.605 2.91 (1.69–5.06) < 0.001 0.6 (0.46–0.78) 0.01
 GGG4 1.18 (0.68–2.05) 0.561 3.88 (2.1–7.18) < 0.001 1.01 (0.99–1.02) 0.005
 GGG5 2.2 (1.39–3.5) 0.001 6.86 (4.22–11.36) < 0.001 1.18 (0.62–2.24) < 0.001

Abbreviations: BCR (Biochemical recurrence); PCSM (Prostate cancer specific mortality).